Roberto Alonzi

3.1k total citations
46 papers, 1.0k citations indexed

About

Roberto Alonzi is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Roberto Alonzi has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 17 papers in Radiation and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Roberto Alonzi's work include Prostate Cancer Diagnosis and Treatment (30 papers), Prostate Cancer Treatment and Research (26 papers) and Advanced Radiotherapy Techniques (17 papers). Roberto Alonzi is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (30 papers), Prostate Cancer Treatment and Research (26 papers) and Advanced Radiotherapy Techniques (17 papers). Roberto Alonzi collaborates with scholars based in United Kingdom, Australia and United States. Roberto Alonzi's co-authors include Peter Hoskin, Anwar R. Padhani, Clare Allen, Robert Hughes, Peter Ostler, Gerry Lowe, Ana M. Rojas, Vicky Goh, N. Jane Taylor and H. Ariyaratne and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Roberto Alonzi

46 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Alonzi United Kingdom 17 607 527 268 130 87 46 1.0k
Amar U. Kishan United States 17 767 1.3× 585 1.1× 626 2.3× 107 0.8× 102 1.2× 125 1.2k
Franziska Walter Germany 19 481 0.8× 454 0.9× 429 1.6× 81 0.6× 87 1.0× 48 959
Dirk Böhmer Germany 16 475 0.8× 197 0.4× 193 0.7× 240 1.8× 76 0.9× 74 900
Riccardo Santoni Italy 19 646 1.1× 393 0.7× 327 1.2× 42 0.3× 141 1.6× 69 1.1k
G. Delpon France 17 524 0.9× 392 0.7× 423 1.6× 162 1.2× 110 1.3× 84 934
A. Lisbona France 21 501 0.8× 648 1.2× 549 2.0× 98 0.8× 120 1.4× 93 1.1k
Iris Ernst Germany 17 544 0.9× 410 0.8× 415 1.5× 47 0.4× 112 1.3× 41 864
Kazufumi Kagawa Japan 14 542 0.9× 249 0.5× 433 1.6× 63 0.5× 178 2.0× 25 829
Sebastian Zschaeck Germany 17 359 0.6× 415 0.8× 125 0.5× 159 1.2× 155 1.8× 63 867
Fabio Cury Canada 19 647 1.1× 229 0.4× 368 1.4× 87 0.7× 204 2.3× 97 1.1k

Countries citing papers authored by Roberto Alonzi

Since Specialization
Citations

This map shows the geographic impact of Roberto Alonzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Alonzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Alonzi more than expected).

Fields of papers citing papers by Roberto Alonzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Alonzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Alonzi. The network helps show where Roberto Alonzi may publish in the future.

Co-authorship network of co-authors of Roberto Alonzi

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Alonzi. A scholar is included among the top collaborators of Roberto Alonzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Alonzi. Roberto Alonzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoskin, Peter, Ana M. Rojas, Peter Ostler, et al.. (2024). Single–dose high-dose-rate brachytherapy versus two and three fractions for locally advanced prostate cancer. Radiotherapy and Oncology. 199. 110426–110426. 4 indexed citations
2.
Parker, Chris, Nina Tunariu, Holly Tovey, et al.. (2023). Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response. JNCI Cancer Spectrum. 7(6). 3 indexed citations
3.
Hussain, Syed A., J.F. Lester, Richard A. Jackson, et al.. (2022). Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 20 indexed citations
4.
Tsang, Y., Roberto Alonzi, William Beasley, et al.. (2022). Changes in Magnetic Resonance Imaging Radiomic Features in Response to Androgen Deprivation Therapy in Patients with Intermediate- and High-risk Prostate Cancer. Clinical Oncology. 34(6). e246–e253. 6 indexed citations
5.
Brown, Stephanie, et al.. (2021). Single dose high-dose-rate brachytherapy with focal dose escalation for prostate cancer: Mature results of a phase 2 clinical trial. Radiotherapy and Oncology. 159. 67–74. 10 indexed citations
6.
Tsang, Y., Gerry Lowe, Roberto Alonzi, et al.. (2021). Dosimetry of local failure with single dose 19 Gy high-dose-rate brachytherapy for prostate cancer. Radiotherapy and Oncology. 157. 93–98. 4 indexed citations
7.
Tunariu, Nina, Holly Tovey, Roberto Alonzi, et al.. (2021). Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223. Clinical Genitourinary Cancer. 19(5). e299–e305. 9 indexed citations
8.
Bhattacharya, Indrani, Mansour T. A. Sharabiani, Roberto Alonzi, & Peter Hoskin. (2019). Hypoxia and angiogenic biomarkers in prostate cancer after external beam radiotherapy (EBRT) alone or combined with high-dose-rate brachytherapy boost (HDR-BTb). Radiotherapy and Oncology. 137. 38–44. 10 indexed citations
9.
Alonzi, Roberto, Andrew Gogbashian, Rob Hughes, et al.. (2018). Single-centre Experience of Use of Radium 223 with Clinical Outcomes Based on Number of Cycles and Bone Marrow Toxicity. Anticancer Research. 38(9). 5423–5427. 14 indexed citations
10.
Alonzi, Roberto, et al.. (2018). The Role of Magnetic Resonance Imaging in Brachytherapy. Clinical Oncology. 30(11). 728–736. 5 indexed citations
12.
Alonzi, Roberto, et al.. (2015). Hypofractionated radiotherapy for localized prostate cancer using three-dimensional conformal radiotherapy technique: 3 years toxicity analysis. Indian Journal of Cancer. 52(4). 654–654. 2 indexed citations
13.
Díez, Patricia, Pittaya Dankulchai, Peter Ostler, et al.. (2014). Dosimetric analysis of urethral strictures following HDR 192Ir brachytherapy as monotherapy for intermediate- and high-risk prostate cancer. Radiotherapy and Oncology. 113(3). 410–413. 13 indexed citations
14.
Dankulchai, Pittaya, Roberto Alonzi, Gerry Lowe, et al.. (2014). Optimal source distribution for focal boosts using high dose rate (HDR) brachytherapy alone in prostate cancer. Radiotherapy and Oncology. 113(1). 121–125. 13 indexed citations
15.
Le, Hien, Ana M. Rojas, Roberto Alonzi, et al.. (2013). The Influence of Prostate Volume on Outcome After High-Dose-Rate Brachytherapy Alone for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 87(2). 270–274. 16 indexed citations
16.
Miles, Kenneth A., Ting‐Yim Lee, Vicky Goh, et al.. (2012). Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography. European Radiology. 22(7). 1430–1441. 162 indexed citations
17.
Alonzi, Roberto, N. Jane Taylor, James Stirling, et al.. (2010). Reproducibility and correlation between quantitative and semiquantitative dynamic and intrinsic susceptibility‐weighted MRI parameters in the benign and malignant human prostate. Journal of Magnetic Resonance Imaging. 32(1). 155–164. 39 indexed citations
18.
Alonzi, Roberto, Anwar R. Padhani, N. Jane Taylor, et al.. (2010). Antivascular Effects of Neoadjuvant Androgen Deprivation for Prostate Cancer: An In Vivo Human Study Using Susceptibility and Relaxivity Dynamic MRI. International Journal of Radiation Oncology*Biology*Physics. 80(3). 721–727. 52 indexed citations
19.
Alonzi, Roberto, Anwar R. Padhani, & Clare Allen. (2007). Dynamic contrast enhanced MRI in prostate cancer. European Journal of Radiology. 63(3). 335–350. 152 indexed citations
20.
Alonzi, Roberto & Peter Hoskin. (2005). Novel Therapies in Bladder Cancer. Clinical Oncology. 17(7). 524–538. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026